These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1094 related items for PubMed ID: 32083585

  • 1. Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
    Silva D, Cardoso S, Guerreiro M, Maroco J, Mendes T, Alves L, Nogueira J, Baldeiras I, Santana I, de Mendonça A.
    J Alzheimers Dis; 2020; 74(3):785-796. PubMed ID: 32083585
    [Abstract] [Full Text] [Related]

  • 2. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
    Zhao A, Li Y, Yan Y, Qiu Y, Li B, Xu W, Wang Y, Liu J, Deng Y.
    Transl Neurodegener; 2020 Aug 03; 9(1):30. PubMed ID: 32741361
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I, Illán-Gala I, Alcolea D, Sánchez-Saudinós MB, Salgado SA, Morenas-Rodríguez E, Subirana A, Videla L, Clarimón J, Carmona-Iragui M, Ribosa-Nogué R, Blesa R, Fortea J, Lleó A.
    J Alzheimers Dis; 2017 Aug 03; 58(3):909-918. PubMed ID: 28527215
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Self-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion.
    Scharre DW, Chang SI, Nagaraja HN, Wheeler NC, Kataki M.
    Alzheimers Res Ther; 2021 Dec 06; 13(1):192. PubMed ID: 34872596
    [Abstract] [Full Text] [Related]

  • 6. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L, Peters O, Lewczuk P, Gruber O, Teipel SJ, Gertz HJ, Jahn H, Jessen F, Kurz A, Luckhaus C, Hüll M, Pantel J, Reischies FM, Schröder J, Wagner M, Rienhoff O, Wolf S, Bauer C, Schuchhardt J, Heuser I, Rüther E, Henn F, Maier W, Wiltfang J, Kornhuber J.
    Alzheimers Res Ther; 2017 Oct 10; 9(1):84. PubMed ID: 29017593
    [Abstract] [Full Text] [Related]

  • 7. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC, Hirni DI, Taylor KI, Berres M, Regeniter A, Gass A, Monsch AU, Sollberger M.
    J Alzheimers Dis; 2015 Oct 10; 44(2):625-33. PubMed ID: 25322924
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K, Barca ML, Eldholm RS, Cavallin L, Šaltytė Benth J, Selbæk G, Brækhus A, Saltvedt I, Engedal K.
    Dement Geriatr Cogn Disord; 2017 Oct 10; 44(1-2):12-24. PubMed ID: 28614836
    [Abstract] [Full Text] [Related]

  • 10. Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease.
    Baldeiras I, Santana I, Leitão MJ, Vieira D, Duro D, Mroczko B, Kornhuber J, Lewczuk P.
    Alzheimers Res Ther; 2019 Jan 05; 11(1):2. PubMed ID: 30611311
    [Abstract] [Full Text] [Related]

  • 11. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
    Defrancesco M, Marksteiner J, Deisenhammer E, Kemmler G, Djurdjevic T, Schocke M.
    J Alzheimers Dis; 2013 Jan 05; 34(3):665-72. PubMed ID: 23254639
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J, Nemoto K, Ikejima C, Bun S, Kakuma T, Mizukami K, Asada T.
    J Alzheimers Dis; 2016 Jan 05; 51(2):405-15. PubMed ID: 26890740
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combined Biomarker Prognosis of Mild Cognitive Impairment: An 11-Year Follow-Up Study in the Alzheimer's Disease Neuroimaging Initiative.
    Spencer BE, Jennings RG, Brewer JB, Alzheimer’s Disease Neuroimaging Initiative.
    J Alzheimers Dis; 2019 Jan 05; 68(4):1549-1559. PubMed ID: 30958366
    [Abstract] [Full Text] [Related]

  • 16. Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance.
    Ewers M, Walsh C, Trojanowski JQ, Shaw LM, Petersen RC, Jack CR, Feldman HH, Bokde AL, Alexander GE, Scheltens P, Vellas B, Dubois B, Weiner M, Hampel H, North American Alzheimer's Disease Neuroimaging Initiative (ADNI).
    Neurobiol Aging; 2012 Jul 05; 33(7):1203-14. PubMed ID: 21159408
    [Abstract] [Full Text] [Related]

  • 17. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M, O Connell T, Johnson S, Cline S, Merikle E, Martenyi F, Simpson K.
    Curr Alzheimer Res; 2018 Jul 05; 15(8):777-788. PubMed ID: 29357799
    [Abstract] [Full Text] [Related]

  • 18. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study.
    Tondelli M, Bedin R, Chiari A, Molinari MA, Bonifacio G, Lelli N, Trenti T, Nichelli P.
    Clin Chem Lab Med; 2015 Feb 05; 53(3):453-60. PubMed ID: 25274948
    [Abstract] [Full Text] [Related]

  • 19. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH, Kim M, Moon SY, Yong SW, Hong JM.
    J Neurol Sci; 2015 Aug 15; 355(1-2):174-9. PubMed ID: 26076880
    [Abstract] [Full Text] [Related]

  • 20. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P, Brousseau M, Chertkow H, Phillips N, Nasreddine ZS.
    J Am Geriatr Soc; 2014 Apr 15; 62(4):679-84. PubMed ID: 24635004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.